Introduction

This conference on Nucleic Acids and Immunity is the second of a series of three, funded by the EU under Framework 7, which will focus on build a synergistic relationship between researchers in these two areas. The epitranscriptome is a new emerging field of research. The aim of the conference is to bring together researchers in the fields of immunology, innate immune nucleic acid sensing and enzymatic modification of nucleic acids. There will also be a medical perspective, discussing how the lack of certain modifications leading to aberrant innate immune recognition of nucleic acids results in disease.

Deadlines

• Nov 15 2016
  Poster abstract deadline

  
• Apr 15 2017
  Oral abstracts deadline

  
• Apr 30 2017
  Standard registration deadline

  

Useful links

• Further event details More information about the event

Speakers

• Shizuo Akira Osaka University, Japan

  http://hostdefense.ifrec.osaka-u.ac.jp/en/members/akira.html
• Mariano Garcia-Blanco University of Texas, USA, United States

  https://www.hbcg.utmb.edu/faculty/garcia-blanco.asp
• Victoria Cowling University of Dundee, UK, United Kingdom

  http://www.lifesci.dundee.ac.uk/people/victoria-cowling
• Eric Miska University of Cambridge, UK, United Kingdom

  http://www.gurdon.cam.ac.uk/research/miska
• Jörg Vogel Universität Würzburg, Germany, Germany

  http://www.imib-wuerzburg.de/research/vogel/group-leader/
• Jan Rehwinkel University of Oxford, UK, United Kingdom

  http://www.imm.ox.ac.uk/jan-rehwinkel
• Yuri Motorin University of Lorraine, France, France

  https://www.researchgate.net/profile/Yuri_Motorin
• Michaela Frye University of Cambridge, UK, United Kingdom

  http://bbsrcdtp.lifesci.cam.ac.uk/directory/frye-michaela
• Gunther Hartmann University of Bonn, Germany, Germany

  http://www.meb.uni-bonn.de/klinpharm/uploads/file/cv/2013-07-15%20Lebenslauf%20Prof.%20Hartmann.pdf

---

Venue

TBC

TBC, TBC, Brno, 60200, Czech Republic

Organised by

Mary O´Connell, Liam Keegan

Contact information

Martin Smolík
CEITEC MU
Contact us by email

---